EUVIMEDEUVIMED entdecken
Crossref

The silent burden of non‐alcoholic fatty liver disease in the elderly: A global burden of disease analysis

Pojsakorn Danpanichkul iD, Cheng Han Ng iD, Mark D Muthiah iD, Kwanjit Duangsonk, Jie Ning Yong, Darren Jun Hao Tan, Wen Hui Lim, Zhen Yu Wong, Nicholas Syn iD, Tsubasa Tsusumi, Hirokazu Takahashi, Mohammad Shadab Siddiqui und 7 weitere

Alimentary Pharmacology & Therapeutics · 2023

DOI: 10.1111/apt.17714 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alimentary Pharmacology & Therapeutics, 2023. Verfasst von Pojsakorn Danpanichkul und 18 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Unit, Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Non‐alcoholic fatty liver disease (NAFLD) represents a significant health threat worldwide. The growing trend towards an aging population, along with an alarming rise in obesity and diabetes, may have significant implications for the burden of NAFLD.

Aim

To assess the impact of NAFLD on the elderly.

Methods

We utilised data from the Global Burden of Disease study between 2010 and 2019 to conduct a comprehensive analysis of the prevalence, mortality, and disability‐adjusted life years (DALYs) associated with NAFLD in the elderly (65–89 years), stratified by region, nation, sociodemographic Index and sex.

Results

Globally, there were an estimated 228 million cases, 87,230 deaths and 1.46 million DALYs attributed to NAFLD in the elderly. Geographically, the Western Pacific region had the highest burden of NAFLD in the elderly. From 2010 to 2019, there was an increasing prevalence rate in all areas, with the most pronounced change observed in the Western Pacific region (annual percentage change (APC) +0.95%, p < 0.001). Over the study period, there was a more rapid increase in NAFLD prevalence in men (APC +0.74%, p < 0.001) than in women (APC +0.63%, p < 0.001). In most regions, death and DALYs rates have declined, with the exception of the Americas, where there was a slight increase (APC +0.25%, p = 0.002 and 0.38%, p < 0.001, respectively).

Conclusion

Over the past decade, the burden of NAFLD in the elderly has been increasing, necessitating immediate and inclusive measures to tackle the rising burden.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseMaleHumansFemaleAgedGlobal Burden of DiseaseQuality-Adjusted Life YearsPrevalenceObesityGlobal Health

Autor:innen und Institutionen

  • Immunology Unit, Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Division of Gastroenterology and Hepatology, Department of Medicine, National University Health System, Singapore.
  • Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Nottingham City Hospital, Nottingham University Hospitals NHS Trust, Nottingham, UK.
  • Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.

ORCID-Profile: Pojsakorn Danpanichkul, Cheng Han Ng, Mark D Muthiah, Nicholas Syn, Daniel Q Huang, Mazen Noureddin, Arun J Sanyal, Karn Wijarnpreecha

Zitieren

APA

Danpanichkul, P., Ng, C. H., Muthiah, M. D., Duangsonk, K., Yong, J. N., Tan, D. J. H., Lim, W. H., Wong, Z. Y., Syn, N., Tsusumi, T., Takahashi, H., Siddiqui, M. S., Wong, V. W., Mantzoros, C. S., Huang, D. Q., Noureddin, M., Loomba, R., Sanyal, A. J., & Wijarnpreecha, K. (2023). The silent burden of non‐alcoholic fatty liver disease in the elderly: A global burden of disease analysis. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.17714

Vancouver

Danpanichkul P, Ng CH, Muthiah MD, Duangsonk K, Yong JN, Tan DJH, et al. The silent burden of non‐alcoholic fatty liver disease in the elderly: A global burden of disease analysis. Alimentary Pharmacology & Therapeutics. 2023. doi:10.1111/apt.17714

BibTeX
@article{Danpanichkul2023,
  author = {Danpanichkul, Pojsakorn and Ng, Cheng Han and Muthiah, Mark D and Duangsonk, Kwanjit and Yong, Jie Ning and Tan, Darren Jun Hao and Lim, Wen Hui and Wong, Zhen Yu and Syn, Nicholas and Tsusumi, Tsubasa and Takahashi, Hirokazu and Siddiqui, Mohammad Shadab and Wong, Vincent Wai-Sun and Mantzoros, Christos S and Huang, Daniel Q and Noureddin, Mazen and Loomba, Rohit and Sanyal, Arun J and Wijarnpreecha, Karn},
  title = {The silent burden of non‐alcoholic fatty liver disease in the elderly: A global burden of disease analysis},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2023},
  doi = {10.1111/apt.17714}
}
Kostenlos starten →